2581
/ 1
Min Read
Dr Reddy’s Laboratories Ltd, the Hyderabad-based pharmaceutical major, has said that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm Cream and its authorised generic to EPI Health, LLC.
DRL said, "Promius Pharma, LLC, has sold its rights of Cloderm (clocortolone pivalate) cream, 0.1 per cent and its authorised generic to EPI Health, LLC, an affiliate of EPI Group, LLC."
Ron Owens, President of EPI Health, said: "We are very pleased to have completed this agreement with Dr. Reddy’s to acquire Cloderm Cream in the United States. Cloderm Cream, and its authorised generic, are widely recognised and time-tested among the dermatology community. The addition of this product to our growing portfolio will support our ongoing efforts to build a successful prescription branded franchise in the US while contributing to EPI Health's goal of becoming a leader in medical dermatology."
